Evidence map›Paper›PMID 12857993›Full record

ReviewImmunologic research2003

Death receptor signaling and autoimmunity.

Richard M Siegel, Jagan Muppidi, Margaret Roberts, Melissa Porter, Zhengqi Wu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. T-cell receptor complex is essential for Fas signal transduction.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Richard M SiegelImmunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health, Bethesda, MD 20892, USA. rsiegel@nih.gov
Jagan Muppidi
Margaret Roberts
Melissa Porter
Zhengqi Wu
National Institutes of Health · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

TNF-receptors and programmed cell death in regulation of autoimmunityZIAAR041133 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2009 to 2019
$9.3M
TNF-Family receptors in immune homeostasis and diseaseZ01AR041133 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SIEGEL, RICHARD M · 2002 to 2008
$2.6M
Cell Biology of Signaling By TNF ReceptorsZ01AR041134 · NIAMS · ARTHRITIS, MUSCULOSKELETAL, SKIN DIS · PI SIEGEL, RICHARD M · 2002 to 2005
–
6 · The paper itself

Abstract

In recent years, it has become clear that self-nonself discrimination by the immune system is driven not so much by the specificities of the antigen receptors themselves, but by ligand-receptor systems that sense the presence of foreign pathogens (toll-like receptors) and those that regulate the balance between cellular proliferation and programmed cell death (tumor necrosis factor [TNF] family ligands and receptors). Interestingly, these two receptor families share a number of common signaling pathways, mediated by the cytoplasmic proteins containing death domains and TRAF domains, which trigger the complementary processes of programmed cell death and inflammation. Both humans and mice with genetic defects in the TNF-receptor family member Fas accumulate abnormal lymphocytes and develop systemic autoimmunity. These findings highlighted the importance of this TNF-receptor family member in the homeostasis of the immune system. In particular, the Fas receptor has been shown to be important in immunoreceptor-mediated apoptosis of activated T and B lymphocytes. Six members of the TNF-receptor superfamily share a common signaling domain with Fas, termed the death domain, that directly links these receptors to the apoptotic machinery of the cell, and, collectively, these receptors have been designated as "death receptors."We are currently investigating a number of important unresolved issues in this field, including: (1). how susceptibility to apoptosis through death receptors is regulated, (2). how Fas and related death receptors function in the maintenance of self-tolerance and homeostasis in the major cell types of the immune system, and (3). recently described nonapoptotic lymphocyte activation signals that use components of death receptor signaling.

Indexed as

AutoimmunityAnimalsApoptosisfas ReceptorHumansSignal TransductionTumor Necrosis Factor-alphafas ReceptorTumor Necrosis Factor-alpha

Identifiers

PMID12857993
OpenAlexW1993129198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.